JUND and breast carcinoma: Most of these conserved TFBSs involved in breast cancer (e.g., AP-1, NFκB, and STAT5), stem cells and embryonic development (e.g., OCT1, PAX6, GATA1), and therefore had the highest potential for regulating CD44 and for being involved in breast cancer.